Target intelligence / Profile preview

Mitochondrial fission regulator 1 (MTFR1)

Target
MTFR1
Molecular classification
Other (mitochondrial protein), Chondrocyte-associated protein, Protein with poly-proline region
01

Overview

Mitochondrial fission regulator 1 (MTFR1) is a poly-proline-rich protein localized to the mitochondria, where it regulates mitochondrial fission and fusion processes integral to cellular energy production, morphology, and stress response[2][3][4][5][13]. The protein is evolutionarily conserved and related to chondrocyte function in certain species. MTFR1 is overexpressed in several cancers, promoting tumor cell proliferation, survival under metabolic stress, and resistance to chemotherapy[2][9]. Its activity is regulated post-translationally, such as via NEK1-mediated phosphorylation, which shifts mitochondrial dynamics toward fusion in response to stress[2]. Given its central role in mitochondrial organization and cellular adaptation, MTFR1 is implicated both as a therapeutic target and a biomarker in oncology and disorders related to mitochondrial dysfunction[2][9][13].

Other names
CHPPRFAM54A2KIAA0009Chondrocyte protein with a poly-proline regionlikely ortholog of chicken chondrocyte protein with a poly proline region
02

Mechanism of action

Drugs targeting MTFR1 may modulate mitochondrial fusion/fission balance and affect cell proliferation, survival, and drug resistance in cancer cells

03

Biological functions

Regulation of mitochondrial fission and fusionMaintenance of mitochondrial organization and morphologyProtection against oxidative damageCellular energy homeostasisModulation of cell proliferation and survival
04

Disease associations

Cancer (colon cancer, lung cancer)Drug resistance (cisplatin resistance)Association with the immune microenvironmentOther mitochondrial dysfunction-related diseases (potential implication)
05

Safety considerations

Targeting mitochondrial dynamics can affect normal cell bioenergeticsPotential for toxicity related to disruption of mitochondrial function in healthy tissueComplex regulation and tissue specificity mean off-target effects or unintended consequences are possible
06

Interacting drugs

Cisplatin
07

Biomarkers

MTFR1 expression may serve as a biomarker for cancer diagnosis, prognosis, and drug resistance, especially in colon and lung cancers

Beyond the preview

Go deeper on Mitochondrial fission regulator 1 (MTFR1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mitochondrial fission regulator 1 (MTFR1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call